DR. Eddy Anglade (Lux Biosciences) and (Isotechnika Pharma (ISA.TO)
Partnering with Isotechnika on Luveniq (for Dry age eye disease)
Isotechnika stock was HALTED ((by SEC) in April 2013 @$ 2.25 per share.
Seems it opened soon after that at $.05cents......
Does anyone know WHY?
Sentiment: Strong Sell
It was halted by the Investment Industry Regulatory Organization of Canada (IIROC), not the SEC. And it was halted because Isotechnika merged with another company called Aurinia and the name and stock ticker for Aurinia were used by the combined company.